BMJ1d
A16 Problem Behaviours Assessment For HD (short Version) Introductory Training Session
Background Recent research has shown that behavioural symptoms in Huntington’s disease (HD) have a significant impact on patients’ quality of life and function. Accurate assessment of behavioural ...
BMJ1d
MANAGEMENT OF INFLAMMATORY NEUROPATHIES
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ3d
Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial
Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK Objective: To perform a pilot trial of occupational therapy (OT) to optimise functional ...
BMJ6d
Root compression on MRI compared with clinical findings in patients with recent onset cervical radiculopathy
1 Department of Neurology, Medical Centre Haaglanden, The Hague, The Netherlands 2 Department of Neurology, Maasstad Hospital, Rotterdam, The Netherlands 3 Department of Radiology, Medical Centre ...
BMJ4d
Towards a multi-arm, multi-stage trial for disease modification in Parkinson’s: The EJS ACT-PD initiative
Background The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease initiative (EJS ACT-PD) is developing a multi-arm, multi-stage (MAMS) platform trial to accelerate identification of ...
BMJ5d
Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: a cohort study
Objective: There are only limited epidemiological studies evaluating the association between vertebrobasilar dolichoectasia (VBD) and outcomes. This study was designed to elucidate the outcome and ...
BMJ2d
Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke
Objective: To investigate whether the extent of white matter lesions (WML) on fluid attenuated inversion recovery (FLAIR) MRI sequences is an independent risk factor for recurrent stroke, and to ...
BMJ3d
Response to rozanolixizumab across treatment cycles in patients with generalised myasthenia gravis: post hoc analysis
Background In the Phase 3 MycarinG (NCT03971422) study, one cycle (six once-weekly subcutaneous infusions) of rozanolixizumab 7mg/kg or 10mg/kg significantly improved myasthenia gravis (MG)-specific ...
BMJ5d
Visual prognosis after indirect traumatic optic neuropathy
5 Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanità, Rome, Italy 6 Department of Opthalmology, University of Sassari, Sassari, Italy Correspondence to: Dr Arturo Carta, ...